In 2020, the Australian equivalent of the FDA approved a testosterone cream for treatment of low sexual desire in postmenopausal women. Javaid has seen the benefits clinically, particularly ...
Testosterone cannot be viewed as a clear-cut answer for women with HSDD; long-term side effects and risk for breast cancer remain uncertain. Hypoactive sexual desire disorder (HSDD) is common in ...